SEC Form 4 · accession 0001161697-16-000797
CATALYST PHARMACEUTICALS, INC. · CPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick J McEnany
Officer — President and CEO · Director
Period of report
Apr 26, 2016
Accepted (ET)
Apr 26, 2016 · 2:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369568
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per share | Apr 26, 2016 | P | 50,000 | $0.6486 | A | 4,287,809 | D |
Table II — derivative securities
No Table II lines on this filing.